PharmaShots Weekly Snapshots (December 13 - 17, 2021)
Published: Dec 17, 2021 | Tags: Ipsen, GENFIT, Elafibranor, Primary Biliary Cholangitis
Published: Dec 17, 2021 | Tags: Merck, Ridgeback, Molnupiravir, P-III, MOVe-OUT Trial, COVID-19, NEJM
Published: Dec 17, 2021 | Tags: BioMarin, Skyline, Gene Therapies, Cardiovascular Diseases
Published: Dec 17, 2021 | Tags: Daiichi Sankyo, Kite, Yescarta, Axicabtagene Ciloleucel, CAR T-Cell Therapy, MHRA, Approval, Lymphoma, Japan
Published: Dec 17, 2021 | Tags: Pfizer, Paxlovid, nirmatrelvir, ritonavir, CHMP, COVID-19
Published: Dec 17, 2021 | Tags: Alpine, Horizon, Protein-Based Therapies, Autoimmune, Inflammatory Diseases
Takeda Reports Submission of NDA to MHLW for Novavax’s NVX-CoV2373 to Treat COVID-19
Published: Dec 16, 2021 | Tags: Takeda, NDA, MHLW, Novavax, NVX-CoV2373, COVID-19
Apellis and Sobi’s Aspaveli (pegcetacoplan) Receives EC’s Approval for the Treatment of PNH
Published: Dec 16, 2021 | Tags: Apellis, Sobi, Aspaveli, pegcetacoplan, EC, Approval, PNH
Published: Dec 16, 2021 | Tags: BMS, Orencia, abatacept, US, FDA, Approval, Acute Graft Versus Host Disease
Published: Dec 16, 2021 | Tags: BioXcel, P-III, TRANQUILITY Program, BXCL501, Alzheimer’s Disease
Published: Dec 16, 2021 | Tags: Jazz, P-IIb, Clinical Trial, Suvecaltamide, JZP385, Essential Tremor
Published: Dec 16, 2021 | Tags: Johnson & Johnson, CHMP, Positive Opinion, COVID-19 Booster Vaccine, COVID-19
Ichnos Signs an Exclusive License Agreement with Almirall for ISB 880 to Treat Autoimmune Diseases
Published: Dec 15, 2021 | Tags: Ichnos, Almirall, ISB 880, Autoimmune Diseases
Published: Dec 15, 2021 | Tags: Genentech, Polivy, polatuzumab vedotin, P-III, POLARIX Study, Diffuse Large B-Cell Lymphoma
Published: Dec 15, 2021 | Tags: Eli Lilly, Mirikizumab, P-III, LUCENT-2, Maintenance Study, Ulcerative Colitis
Published: Dec 15, 2021 | Tags: Pfizer, Xeljanz, tofacitinib, US, FDA, Approval, Active Ankylosing Spondylitis
CSL to Acquire Vifor Pharma for ~$11.7B
Published: Dec 15, 2021 | Tags: CSL, Acquire, Vifor Pharma, ~$11.7B
Published: Dec 15, 2021 | Tags: BMS, Immatics, IMA401, Cancer
Published: Dec 14, 2021 | Tags: Junshi, Coherus, Toripalimab, P-III, CHOICE-01 Trial, Non-Small Cell Lung Cancer
Published: Dec 14, 2021 | Tags: AstraZeneca, Samsung Biologics, AZD7442, COVID-19
Published: Dec 14, 2021 | Tags: Janssen, Teclistamab, MajesTEC-1 Study, Multiple Myeloma, ASH 2021
Published: Dec 14, 2021 | Tags: Arbutus, Qilu, AB-729, Hepatitis B
Lilly Collaborates with Foghorn to Develop Novel Oncology Therapies for the Treatment of Cancer
Published: Dec 14, 2021 | Tags: Lilly, Foghorn, Novel Oncology Therapies, Cancer
Pfizer to Acquire Arena for ~ $6.7B
Published: Dec 14, 2021 | Tags: Pfizer, Acquire, Arena, ~ $6.7B
Published: Dec 13, 2021 | Tags: BMS, Antengene, ATG-017, Opdivo, nivolumab, Advanced Solid Tumors
Published: Dec 13, 2021 | Tags: Jazz, PharmaMar, P-III, LAGOON Trial, Zepzelca, lurbinectedin, Small Cell Lung Cancer
Published: Dec 13, 2021 | Tags: AstraZeneca, Calquence, P-III, ASCEND, Trial, Chronic Lymphocytic Leukaemia, ASH 2021
Published: Dec 13, 2021 | Tags: Sanofi, Dupixent, dupilumab, P-III, Trial, Atopic Dermatitis, RAD 2021
Published: Dec 13, 2021 | Tags: AbbVie SpringWorks, ABBV-383, Nirogacestat, Multiple Myeloma
Published: Dec 13, 2021 | Tags: Lilly, Regor, Novel Therapies, Metabolic Disorders
Related Post: PharmaShots Weekly Snapshots (December 06-10, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com